Drugs / Platelet Lysate
Platelet Lysate
Trials 9 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT02979912 | Feb 2017 → Jan 2019 | corneal disorder | Hanan Jafar | Completed | No outcome recorded |
| Phase 1/2 | NCT02941419 | Mar 2013 → Sep 2016 | limb ischemia | University of Jordan | Completed | No outcome recorded |
| Phase 1/2 | NCT01643629 | Jan → Oct 2012 | androgenetic alopecia | Kasiak Research Pvt. Ltd. | Unknown | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT05671250 | Jul 2021 → Nov 2022 | ulcer of lower limbs | Mansoura University | Completed | No outcome recorded |
| Phase 2 | NCT05311514 | Apr 2021 → Nov 2024 | chronic graft versus host disease | St. Petersburg State Pavlov Medical University | Completed | No outcome recorded |
| Phase 2 | NCT02958761 | Aug 2010 → Jan 2014 | osteoarthritis, knee | Fondazione IRCCS Policlinico San Matteo di Pavia | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT05287867 | May 2022 → Dec 2026 expected | lumbar disk degenerative disorder | Regenexx, LLC | Recruiting | No outcome recorded |
| — | NCT04487691 | Dec 2020 → Jun 2021 | COVID-19 | Regenexx, LLC | Terminated | No outcome recorded |
| — | NCT03618979 | May 2019 → Jun 2022 | — | Regenexx, LLC | Terminated | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03297814 Comparator | Apr 2018 → Mar 2020 | peripheral arterial disease | Sophia Al-Adwan | Unknown | No outcome recorded |
| Phase 1/2 | NCT02972528 Comparator | Feb 2018 → Feb 2020 | ulcer of lower limbs | Hanan Jafar | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet lysate | “A Randomized Controlled Trial to Assess the Effects of Autologous Platelet Rich Plasma, Platelet Lysate, and Platelet Poor Plasma on Atrophied Multifidus Muscles in Patients...” NCT03618979 ↗9“Platelet-lysate loaded sustained release thermo-gelling formulation” NCT05671250 ↗ |
| Known as | HPL | “Autologous Human Platelet Lysate (HPL)” NCT01643629 ↗ |
| Known as | Human Platelet Lysate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01643629 ↗ |
| Route | Intramuscular | “Platelet lysate will be injected intramuscularly at different sites of the gastrocnemius muscle.” NCT02941419 ↗ |